What if clinical trial participants unionized?

And how do you know if a “positive” study is positive?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, we dig into Biogen’s aforementioned data in Alzheimer’s disease, with on-the-ground takes from experts at a scientific conference. Then, STAT’s Eric Boodman joins us to spin a drug-discovery yarn involving one-eyed sheep, Basque farmers, and the quest to treat a rare form of cancer.

You can listen to the episode here. To listen to future episodes, be sure to sign up on Apple Podcasts, Stitcher, Spotify, or wherever you get your podcasts.